EU-related Activities

Radioligand Therapy (RLT) Academy

As part of a pan-European consortium managed by the RPP Agency, the EANM and its partners were recently awarded an Erasmus+ grant to build a Radioligand Therapy (RLT) Academy. This initiative is a first-of-its-kind European-level training opportunity. Over 30 months, the EANM will co-shape the academy with its consortium partners. These partners include leading institutions in the field and the EAU as a clinical partner. Furthermore, the academy is supported by the European Oncology Nursing Society (EONS), Advanced Accelerator Applications (AAA) and the International Atomic Energy Agency (IAEA), which act as associate partners.


This website uses cookies. Learn more